10.57USD-3.12%Mkt Cap: 363.17M USDP/E: 1052.00Last update: 2026-06-01
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphala…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap363.17M USD
Enterprise Value283.75M USD
Revenue (TTM)90.44M USD
Gross Profit73.43M USD
Net Income (TTM)2.70M USD
Revenue/Share2.501 USD
Last Price10.57 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees156
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)1052.00
P/E (Forward)-28.12
PEG1.60
EV/EBITDA-214.64
EV/Revenue3.14
P/S4.11
P/B3.30
EPS (TTM)0.01
EPS (Forward)-0.38
52W Range
8.12027% of range17.35
52W High17.35 USD
52W Low8.120 USD
Profitability
Gross Margin86.16%
Oper. Margin-6.55%
EBITDA Margin-1.46%
Profit Margin3.17%
ROE2.43%
ROA2.18%
Growth
Revenue Growth26.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF22.52M USD
CapEx (TTM)1.55M USD
FCF Margin21.73%
FCF Yield5.41%
Net Debt-88.39M USD
Net Debt/EBITDA66.86
Balance Sheet
Debt/Equity0.01
Current Ratio11.24
Quick Ratio9.72
Book Value/Sh3.270 USD
Cash/Share2.587 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 24, 2019
Splits
Last Split1:700
Split DateDec 24, 2019
Analyst Consensus
Rating—
Target (Mean)21.29 USD
Target Range18.00 USD – 29.76 USD
# Analysts6
Ownership
Shares Out.34.52M
Float28.60M
Insiders8.13%
Institutions48.80%
Short Interest
Short Ratio8.4d
Short % Float10.82%
Short % Out.9.94%
Shares Short3.43M
Short (prev mo.)3.86M
Technical
SMA 5010.44 (+1.2%)
SMA 20010.21 (+3.5%)
Beta0.54
S&P 52W Chg27.94%
Avg Vol (30d)401.55K
Avg Vol (10d)441.39K
Technical Indicators
RSI (14)49.8
MACD0.1055
MACD Signal0.1878
MACD Hist.-0.0823
BB Upper11.67 USD
BB Middle11.16 USD
BB Lower10.65 USD
BB Width9.09%
ATR (14)0.5131 USD
Vol Ratio (20d)0.61x